Managed Access Programs for PKC412, Midostaurin

Clinical trial NCT05219266 · NO_LONGER_AVAILABLE

Trial details

NCT number: NCT05219266
Sponsor: Novartis Pharmaceuticals
Status: NO_LONGER_AVAILABLE
Study type: EXPANDED_ACCESS

FMS-Like Tyrosine Kinase 3 (FLT3)-Mutated Acute Myeloid Leukemia Acute Myeloid Leukemia Aggressive Systemic Mastocytosis Mast Cell Leukemia Systemic Mastocytosis With an Associated Hematologic Neoplasm

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.